Organigram Holdings Inc Announces CFO Retirement and Interim Replacement

Business by 2FIRSTS.ai
Nov.16.2023
Organigram Holdings Inc Announces CFO Retirement and Interim Replacement
Organigram Holdings Inc's CFO, Derrick West, will step down for health reasons, with Paolo De Luca serving as temporary CFO.

According to a press release from businesswire, Canadian cannabis company Organigram Holdings Inc, which is partly owned by British American Tobacco, has announced that Chief Financial Officer Derrick West will take a leave of absence starting at the end of this month to focus on his health following a surgery. In the interim, Chief Strategy Officer Paolo De Luca will assume the role of temporary Chief Financial Officer, starting November 13, 2023, until the company finds a new permanent CFO.

 

The Board of Directors expresses gratitude to Mr. West for his contributions to the company's financial stability and the implementation of the ERP system, and wishes him success in his new chapter of life.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

Related Topics